This study is in progress, not accepting new patients
The FARAPULSE ADVENT PIVOTAL Trial PFA System vs SOC Ablation for Paroxysmal Atrial Fibrillation
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Edward Gerstenfeld
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Edward Gerstenfeld
Dr Gerstenfeld is the Melvin Scheinman Endowed Professor of Medicine and Chief of the Section of Cardiac Electrophysiology at UCSF.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Farapulse, Inc.
- ID
- NCT04612244
- Study Type
- Interventional
- Participants
- Expecting 900 study participants
- Last Updated